Literature DB >> 30451737

Genes and environment in chronic kidney disease hotspots.

David J Friedman1.   

Abstract

PURPOSE OF REVIEW: Chronic kidney disease (CKD) can cluster in geographic locations or in people of particular genetic ancestries. We explore APOL1 nephropathy and Balkan nephropathy as examples of CKD clustering that illustrate genetics and environment conspiring to cause high rates of kidney disease. Unexplained hotspots of kidney disease in Asia and Central America are then considered from the perspective of potential gene × environment interactions. RECENT
FINDINGS: We report on evidence supporting both genes and environment in these CKD hotspots. Differing genetic susceptibility between populations and within populations may explain why causal environmental risk factors have been so hard to identify conclusively. Similarly, one cannot explain why these epidemics of kidney disease are happening now without invoking environmental changes.
SUMMARY: Approaches to these CKD hotspots are of necessity becoming more holistic. Genetic studies may help us identify the environmental triggers by teaching us about disease biology and may empower environmental risk factor studies by allowing for stratification of study participants by genetic susceptibility.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30451737      PMCID: PMC6763202          DOI: 10.1097/MNH.0000000000000470

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  65 in total

1.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

2.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.

Authors:  Jeffrey B Kopp; Michael W Smith; George W Nelson; Randall C Johnson; Barry I Freedman; Donald W Bowden; Taras Oleksyk; Louise M McKenzie; Hiroshi Kajiyama; Tejinder S Ahuja; Jeffrey S Berns; William Briggs; Monique E Cho; Richard A Dart; Paul L Kimmel; Stephen M Korbet; Donna M Michel; Michele H Mokrzycki; Jeffrey R Schelling; Eric Simon; Howard Trachtman; David Vlahov; Cheryl A Winkler
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

3.  Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism.

Authors:  Marcus D Säemann; Thomas Weichhart; Maximilian Zeyda; Günther Staffler; Michael Schunn; Karl M Stuhlmeier; Yuri Sobanov; Thomas M Stulnig; Shizuo Akira; Alexander von Gabain; Uwe von Ahsen; Walter H Hörl; Gerhard J Zlabinger
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

4.  Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.

Authors:  Daniel F Gudbjartsson; Hilma Holm; Olafur S Indridason; Gudmar Thorleifsson; Vidar Edvardsson; Patrick Sulem; Femmie de Vegt; Frank C H d'Ancona; Martin den Heijer; Jack F M Wetzels; Leifur Franzson; Thorunn Rafnar; Kristleifur Kristjansson; Unnur S Bjornsdottir; Gudmundur I Eyjolfsson; Lambertus A Kiemeney; Augustine Kong; Runolfur Palsson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  PLoS Genet       Date:  2010-07-29       Impact factor: 5.917

5.  MYH9 is associated with nondiabetic end-stage renal disease in African Americans.

Authors:  W H Linda Kao; Michael J Klag; Lucy A Meoni; David Reich; Yvette Berthier-Schaad; Man Li; Josef Coresh; Nick Patterson; Arti Tandon; Neil R Powe; Nancy E Fink; John H Sadler; Matthew R Weir; Hanna E Abboud; Sharon G Adler; Jasmin Divers; Sudha K Iyengar; Barry I Freedman; Paul L Kimmel; William C Knowler; Orly F Kohn; Kristopher Kramp; David J Leehey; Susanne B Nicholas; Madeleine V Pahl; Jeffrey R Schelling; John R Sedor; Denyse Thornley-Brown; Cheryl A Winkler; Michael W Smith; Rulan S Parekh
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

Review 6.  Aristolochic acid nephropathy: a worldwide problem.

Authors:  Frédéric D Debelle; Jean-Louis Vanherweghem; Joëlle L Nortier
Journal:  Kidney Int       Date:  2008-04-16       Impact factor: 10.612

7.  Multiple loci associated with indices of renal function and chronic kidney disease.

Authors:  Anna Köttgen; Nicole L Glazer; Abbas Dehghan; Shih-Jen Hwang; Ronit Katz; Man Li; Qiong Yang; Vilmundur Gudnason; Lenore J Launer; Tamara B Harris; Albert V Smith; Dan E Arking; Brad C Astor; Eric Boerwinkle; Georg B Ehret; Ingo Ruczinski; Robert B Scharpf; Yii-Der Ida Chen; Ian H de Boer; Talin Haritunians; Thomas Lumley; Mark Sarnak; David Siscovick; Emelia J Benjamin; Daniel Levy; Ashish Upadhyay; Yurii S Aulchenko; Albert Hofman; Fernando Rivadeneira; André G Uitterlinden; Cornelia M van Duijn; Daniel I Chasman; Guillaume Paré; Paul M Ridker; W H Linda Kao; Jacqueline C Witteman; Josef Coresh; Michael G Shlipak; Caroline S Fox
Journal:  Nat Genet       Date:  2009-05-10       Impact factor: 38.330

8.  Chronic renal failure in North Central Province of Sri Lanka: an environmentally induced disease.

Authors:  Kamani P Wanigasuriya; Roshini J Peiris-John; Rajitha Wickremasinghe; Ariyasena Hittarage
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-07-23       Impact factor: 2.184

9.  [End-stage renal disease among patients in a referral hospital in El Salvador].

Authors:  Ramón García Trabanino; Raúl Aguilar; Carlos Reyes Silva; Manuel Ortiz Mercado; Ricardo Leiva Merino
Journal:  Rev Panam Salud Publica       Date:  2002-09

10.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.

Authors:  Shay Tzur; Saharon Rosset; Revital Shemer; Guennady Yudkovsky; Sara Selig; Ayele Tarekegn; Endashaw Bekele; Neil Bradman; Walter G Wasser; Doron M Behar; Karl Skorecki
Journal:  Hum Genet       Date:  2010-07-16       Impact factor: 4.132

View more
  2 in total

1.  [Correlation of type 2 diabetes and impaired glucose regulation with chronic kidney disease in middle-aged and elderly individuals].

Authors:  Qiangmei Wang; Jieyu Zhen; Conghui Guan; Nan Zhao; Jinjin Liu; Hongli Li; Songbo Fu; Xulei Tang; Yanping Han; Shan Su; Di Zhang; Lijuan Liu; Donghu Zhen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-10-30

Review 2.  New Insights and Challenges Associated With IgA Vasculitis and IgA Vasculitis With Nephritis-Is It Time to Change the Paradigm of the Most Common Systemic Vasculitis in Childhood?

Authors:  Marija Jelusic; Mario Sestan; Teresa Giani; Rolando Cimaz
Journal:  Front Pediatr       Date:  2022-03-15       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.